İ. YAYLIM ERALTAN Et Al. , "sTRAIL Serum Levels and TRAIL 1595 Genotypes: Associations with Progress and Prognosis of Colorectal Carcinoma.," Journal of Cancer Therapy , vol.3, pp.941-947, 2012
YAYLIM ERALTAN, İ. Et Al. 2012. sTRAIL Serum Levels and TRAIL 1595 Genotypes: Associations with Progress and Prognosis of Colorectal Carcinoma.. Journal of Cancer Therapy , vol.3 , 941-947.
YAYLIM ERALTAN, İ., Özkan, N. E., Turan, S., Korkmaz, G., Yıldız, Y., Cacına, C., ... Toptaş, B.(2012). sTRAIL Serum Levels and TRAIL 1595 Genotypes: Associations with Progress and Prognosis of Colorectal Carcinoma.. Journal of Cancer Therapy , vol.3, 941-947.
YAYLIM ERALTAN, İlhan Et Al. "sTRAIL Serum Levels and TRAIL 1595 Genotypes: Associations with Progress and Prognosis of Colorectal Carcinoma.," Journal of Cancer Therapy , vol.3, 941-947, 2012
YAYLIM ERALTAN, İlhan Et Al. "sTRAIL Serum Levels and TRAIL 1595 Genotypes: Associations with Progress and Prognosis of Colorectal Carcinoma.." Journal of Cancer Therapy , vol.3, pp.941-947, 2012
YAYLIM ERALTAN, İ. Et Al. (2012) . "sTRAIL Serum Levels and TRAIL 1595 Genotypes: Associations with Progress and Prognosis of Colorectal Carcinoma.." Journal of Cancer Therapy , vol.3, pp.941-947.
@article{article, author={İlhan YAYLIM Et Al. }, title={sTRAIL Serum Levels and TRAIL 1595 Genotypes: Associations with Progress and Prognosis of Colorectal Carcinoma.}, journal={Journal of Cancer Therapy}, year=2012, pages={941-947} }